Role of HIF-1 and NF-κB Transcription Factors in the Modulation of Transferrin Receptor by Inflammatory and Anti-inflammatory Signals*
暂无分享,去创建一个
[1] R. Schreiber,et al. HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. , 2008, Blood.
[2] G. Semenza,et al. LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner. , 2008, Antioxidants & redox signaling.
[3] H. Niederegger,et al. Autocrine formation of hepcidin induces iron retention in human monocytes. , 2008, Blood.
[4] G. Melillo,et al. Synergystic induction of HIF-1α transcriptional activity by hypoxia and lipopolysaccharide in macrophages , 2008, Cell cycle.
[5] Elizabeth C. Theil,et al. The family of iron responsive RNA structures regulated by changes in cellular iron and oxygen , 2007, Cellular and Molecular Life Sciences.
[6] M. Nitti,et al. Adenosine A2a receptor‐mediated, normoxic induction of HIF‐1 through PKC and PI‐3K‐dependent pathways in macrophages , 2007, Journal of leukocyte biology.
[7] A. Bowie,et al. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.
[8] T. Kietzmann,et al. Reactive Oxygen Species Activate the HIF-1&agr; Promoter Via a Functional NF&kgr;B Site , 2007 .
[9] S. Colgan,et al. Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. , 2007, The Journal of clinical investigation.
[10] S. Leibovich,et al. Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter. , 2006, Molecular biology of the cell.
[11] R. Simpson,et al. Tumour necrosis factor α causes hypoferraemia and reduced intestinal iron absorption in mice , 2006 .
[12] S. Frede,et al. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. , 2006, The Biochemical journal.
[13] V. Nizet,et al. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. , 2006, Blood.
[14] G. Cairo,et al. A precious metal: Iron, an essential nutrient for all cells , 2006, Genes & Nutrition.
[15] S. Pingle,et al. Activation of the Adenosine A3 Receptor in RAW 264.7 Cells Inhibits Lipopolysaccharide-Stimulated Tumor Necrosis Factor-α Release by Reducing Calcium-Dependent Activation of Nuclear Factor-κB and Extracellular Signal-Regulated Kinase 1/2 , 2006, Journal of Pharmacology and Experimental Therapeutics.
[16] E. Vizi,et al. Adenosine Augments IL-10 Production by Macrophages through an A2B Receptor-Mediated Posttranscriptional Mechanism1 , 2005, The Journal of Immunology.
[17] C. Beaumont,et al. Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. , 2005, Blood.
[18] T. Ganz,et al. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. , 2005, Blood.
[19] M. Rettig,et al. Mechanism of von Hippel-Lindau Protein-Mediated Suppression of Nuclear Factor kappa B Activity , 2005, Molecular and Cellular Biology.
[20] D. Swinkels,et al. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. , 2005, Blood.
[21] M. Sitkovsky,et al. Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors , 2005, Nature Reviews Immunology.
[22] G. Cairo,et al. Loss of the von Hippel Lindau Tumor Suppressor Disrupts Iron Homeostasis in Renal Carcinoma Cells* , 2005, Journal of Biological Chemistry.
[23] D. Haile,et al. Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages. , 2005, Blood cells, molecules & diseases.
[24] G. Weiss. Modification of iron regulation by the inflammatory response. , 2005, Best practice & research. Clinical haematology.
[25] M. Déry,et al. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. , 2005, The international journal of biochemistry & cell biology.
[26] J. Linden. Adenosine in Tissue Protection and Tissue Regeneration , 2005, Molecular Pharmacology.
[27] C. Print,et al. Hypoxia-induced neutrophil survival is mediated by HIF-1α–dependent NF-κB activity , 2005, The Journal of experimental medicine.
[28] Jerry Kaplan,et al. Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.
[29] G. Goodall,et al. Functional Integrity of Nuclear Factor κB, Phosphatidylinositol 3′-Kinase, and Mitogen-Activated Protein Kinase Signaling Allows Tumor Necrosis Factor α-Evoked Bcl-2 Expression to Provoke Internal Ribosome Entry Site-Dependent Translation of Hypoxia-Inducible Factor 1α , 2004, Cancer Research.
[30] C. Ponti,et al. Hepatocyte growth factor-activated NF-κB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines , 2004 .
[31] D. Livingston,et al. Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. , 2004, Cancer cell.
[32] Manfred Thiel,et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. , 2004, Annual review of immunology.
[33] Caroline C. Blouin,et al. Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. , 2004, Blood.
[34] C. Szabó,et al. ADENOSINE STIMULATES CREB ACTIVATION IN MACROPHAGES VIA A P38 MAPK‐MEDIATED MECHANISM: 165 , 2003 .
[35] L. Tacchini,et al. Hepatocyte growth factor signaling regulates transactivation of genes belonging to the plasminogen activation system via hypoxia inducible factor-1. , 2003, Experimental cell research.
[36] Tomas Ganz,et al. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. , 2003, Blood.
[37] E. Zandi,et al. Signaling Role of Intracellular Iron in NF-κB Activation* , 2003, The Journal of Biological Chemistry.
[38] B. Aggarwal,et al. Adenosine suppresses activation of nuclear factor-κB selectively induced by tumor necrosis factor in different cell types , 2003, Oncogene.
[39] M. Knutson,et al. Iron Metabolism in the Reticuloendothelial System , 2003, Critical reviews in biochemistry and molecular biology.
[40] A. Ghio,et al. Regulation of Reticuloendothelial Iron Transporter MTP1 (Slc11a3) by Inflammation* , 2002, The Journal of Biological Chemistry.
[41] P. Ponka,et al. Nitrogen monoxide-mediated control of ferritin synthesis: Implications for macrophage iron homeostasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[42] G. Cairo,et al. Transferrin receptor gene expression and transferrin‐bound iron uptake are increased during postischemic rat liver reperfusion , 2002, Hepatology.
[43] G. Minotti,et al. The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage. , 2002, Free radical biology & medicine.
[44] F. Torti,et al. Regulation of ferritin genes and protein. , 2002, Blood.
[45] D. Taramelli,et al. Macrophage Preconditioning with Synthetic Malaria Pigment Reduces Cytokine Production via Heme Iron-Dependent Oxidative Stress , 2000, Laboratory Investigation.
[46] G. Cairo,et al. Iron regulatory proteins in pathobiology. , 2000, The Biochemical journal.
[47] N. Perkins. The Rel/NF-κB family: friend and foe , 2000 .
[48] K. Eng,et al. Adenosine and its receptor agonists regulate nitric oxide production and RAW 264.7 macrophages via both receptor binding and its downstream metabolites-inosine. , 2000, Life sciences.
[49] P. Ponka,et al. Effects of Interferon-γ and Lipopolysaccharide on Macrophage Iron Metabolism Are Mediated by Nitric Oxide-induced Degradation of Iron Regulatory Protein 2* , 2000, The Journal of Biological Chemistry.
[50] P. Ponka,et al. Control of Transferrin Receptor Expression via Nitric Oxide-mediated Modulation of Iron-regulatory Protein 2* , 1999, The Journal of Biological Chemistry.
[51] L. Bianchi,et al. HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. , 1999, Nucleic acids research.
[52] V. Mulero,et al. Regulation of iron metabolism in murine J774 macrophages: role of nitric oxide-dependent and -independent pathways following activation with gamma interferon and lipopolysaccharide. , 1999, Blood.
[53] C. Lok,et al. Identification of a Hypoxia Response Element in the Transferrin Receptor Gene* , 1999, The Journal of Biological Chemistry.
[54] L. Bianchi,et al. Transferrin Receptor Induction by Hypoxia , 1999, The Journal of Biological Chemistry.
[55] G. Semenza,et al. Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity. , 1998, Molecular pharmacology.
[56] D. Taramelli,et al. Nitric oxide-mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: role of selective iron regulatory protein-2 downregulation. , 1998, Blood.
[57] E. Vizi,et al. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. , 1996, Journal of immunology.
[58] M. Hentze,et al. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[59] A. Tomasi,et al. Induction of Ferritin Synthesis by Oxidative Stress , 1995, The Journal of Biological Chemistry.
[60] G. Semenza,et al. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. , 1993, Blood.
[61] T. Byrd,et al. Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma. , 1993, The Journal of clinical investigation.
[62] F. Torti,et al. Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain. , 1991, The Journal of biological chemistry.
[63] P. Ghezzi,et al. Dexamethasone Modulation of In Vivo Effects of Endotoxin, Tumor Necrosis Factor, and Interleukin‐1 on Liver Cytochrome P‐450, Plasma Fibrinogen, and Serum Iron , 1989, Journal of leukocyte biology.
[64] Barbara Neupert,et al. A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA , 1989, Cell.
[65] L. Moldawer,et al. Cachectin/tumor necrosis factor‐α alters red blood cell kinetics and induces anemia in vivo , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[66] A. Konijn,et al. Ferritin Synthesis in Inflammation: II. MECHANISM OF INCREASED FERRITIN SYNTHESIS , 1981, British journal of haematology.
[67] Jerry Kaplan,et al. Regulation of iron acquisition and storage: consequences for iron-linked disorders , 2008, Nature Reviews Molecular Cell Biology.
[68] B. Cronstein,et al. Adenosine: an endogenous regulator of innate immunity. , 2004, Trends in immunology.
[69] M. Gassmann,et al. The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. , 1995, Nucleic acids research.
[70] O. Røkke,et al. Early fall of circulating iron and rapid rise of lactoferrin in septicemia and endotoxemia: an early defence mechanism. , 1989, Scandinavian journal of infectious diseases.